PROS1 and COVID-19: In particular, we generated COVID-19 vaccine candidates based on the MVA vector expressing either a human codon optimized full-length native spike (S) protein (MVA-CoV2-S and MVA-Δ-CoV2-S) or a full-length S protein stabilized in the prefusion conformation [MVA-CoV2-S(3P)].